Balyasny Asset Management LLC Abeona Therapeutics Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 34,128 shares of ABEO stock, worth $199,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,128Holding current value
$199,648% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ABEO
# of Institutions
69Shares Held
28.7MCall Options Held
631KPut Options Held
2.9K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$22.8 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.6 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$20.6 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$12.4 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$12.2 Million7.9% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $34.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...